Erratum: Progressive leukoencephalopathy associated with aluminum deposits in myelin sheath (Journal of Child Neurology (2008) vol. 23 (938-943) 10.1177/0883073808315413);Progressive leukoencephalopathy associated with aluminum deposits in myelin sheath

Journal of Child Neurology

Volumn 23, Issue 8, 2008, Pages 938-943

  Itoh, M ^a,b,c   Suzuki, Y ^a,b,c   Sugai, K ^a,b,c   Ozuka, N ^a,b,c   Ohsawa, M ^a,b,c   Otsuki, T ^a,b,c   Goto, Y ^a,b,c  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b Department of Pediatrics   (Japan)

^c Toyama Medical and Pharmaceutical University   (Japan)

Author keywords

Aluminum; Electron spectroscopic imaging; Leukoencephalopathy

Indexed keywords

ALUMINUM; FERRITIN; MYELIN BASIC PROTEIN;

ADULT; ALUMINUM METABOLISM; ANAMNESIS; ANISOCORIA; ARTICLE; ATAXIA; BRAIN BIOPSY; BRAIN EDEMA; BRAIN LATERAL VENTRICLE; BRAIN TISSUE; BRAIN VENTRICLE DILATATION; CASE REPORT; CLINICAL FEATURE; COMA; DECOMPRESSION SURGERY; DEMYELINATION; DEPRESSION; ELECTROENCEPHALOGRAM; EVOKED VISUAL RESPONSE; FEMALE; HEAD INJURY; HEMIPARESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERREFLEXIA; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; LEARNING DISORDER; LEUKOENCEPHALOPATHY; MENTAL DEFICIENCY; MENTAL DETERIORATION; MOTOR DYSFUNCTION; MOTOR NERVE CONDUCTION; MYELIN SHEATH; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSISTENT VEGETATIVE STATE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; QUADRIPLEGIA; SLOW BRAIN WAVE; SPECTROSCOPY; TISSUE LEVEL; WHITE MATTER;

EID: 48449104658     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073808327267     Document Type: Erratum

References (20)

1. van der Knaap MS, Kamphorst W., Barth PG, et al. Phenotypic variation in leukoencephalopathy with vanishing white matter. Neurology. 1998;51:540-547.
2. Leegwater PA, Vermeulen G., Könst AA, et al. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet. 2001;29:383-388.
3. Naidu S., Bibat G., Lin D., et al. Progressive cavitating leukoencephalopathy: A novel childhood disease. Ann Neurol. 2005;58:929-938.
4. Poser CM, Goutières F., Carpentier MA, Aicardi J. Schilder's myelinoclastic diffuse sclerosis. Pediatrics. 1986;77:107-112.
5. Authier FJ, Cherin P., Creange A., et al. Central nervous system disease in patients with macrophagic myofasciitis. Brain. 2001;124:974-983.
6. Exley C., Esiri MM Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UK. J Neurol Neurosurg Psychiatry. 2006;77:877-879.
7. Lapresle J., Duckett S., Galle P., Cartier L. Clinical, anatomical and biophysical data on a case of encephalopathy with aluminum deposits. C R Seances Soc Biol Fil. 1975;169:282-285.
8. Reusche E., Pilz P., Oberascher G., et al. Subacute fatal aluminum encephalopathy after reconstructive otoneurosurgery: A case report. Hum Pathol. 2001;32:1136-1140.
9. Shirabe T., Irie K., Uchida M. Autopsy case of aluminum encephalopathy. Neuropathology. 2002;22:206-210.
10. Shiraishi K., Itoh M., Sano K., et al. Myelination of a fetus with Pelizaeus-Merzbacher disease: Immunopathological study. Ann Neurol. 2003;54:259-262.
11. Futaesaku Y., Yano M., Ueno M., et al. Principles of electron spectroscopic imaging (ESI) in hard tissue biology. J Hard Tissue Biol. 1998;7:1-10.
12. Fleming J., Joshi JG Ferritin: Isolation of aluminum-ferritin complex from brain. Proc Natl Acad Sci USA. 1987;84:7866-7870.
13. Moore PB, Edwardson JA, Ferrier IN, et al. Gastrointestinal absorption of aluminum is increased in Down's syndrome. Biol Psychiatry. 1997;41:488-492.
14. Farrar G., Altmann P., Welch S., et al. Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: Possible mechanism for accumulation of aluminium in brain. Lancet. 1990;335:747-750.
15. Hodgkins PS, Prasher V., Farrar G., Armstrong R., Sturman S., Corbett J., Blair JA Reduced transferring binding in Down syndrome: A route to senile plaque formation and dementia. Neuroreport. 1993;5:21-24.
16. Leveugle B., Spik G., Perl DP, et al. The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: A comparative immunohistochemical analysis. Brain Res. 1994;650:20-31.
17. Miu AC, Olteanu AI, Miclea M. A behavioral and ultrastructural dissection of the interference of aluminum with aging. J Alzheimers Dis. 2004;6:315-328.
18. Verstraeten SV, Golub MS, Keen CL, Oteiza PI Myelin is a preferential target of aluminum-mediated oxidative damage. Arch Biochem Biophys. 1997;344:289-294.
19. Golub MS, Han B., Keen CL Aluminum uptake and effects on transferrin mediated iron uptake in primary cultures of rat neurons, astrocytes and oligodendrocytes. Neurotoxicology. 1999;20:961-970.
20. Nehru B., Anand P. Oxidative damage following chronic aluminium exposure in adult and pup rat brains. J Trace Elem Med Biol. 2005;19:203-208.